Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 10Unknown 5Terminated 4Withdrawn 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

Treatment 1Leukemia, Myeloid, Acute 1

Interventions

pembrolizumab 562Specimen Handling 490Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 406Radiotherapy 353Gemcitabine 314Bevacizumab 313Paclitaxel 298Biopsy 290Drug Therapy 283Blood Specimen Collection 248Capecitabine 245Oxaliplatin 241fludarabine 240Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 205Dexamethasone 187Radiosurgery 182Rituximab 159Standard of Care 158Pemetrexed 156Surgical Procedures, Operative 148durvalumab 145atezolizumab 145Leucovorin 139

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all
NCT06682117 2026-04-02

Neo-DCV-001

Fudan University

Phase NA Recruiting
9 enrolled
Other solid neoplasm

Treatment

NCT05000801 2021-08-20

Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia

Affiliated Hospital to Academy of Military Medical Sciences

Phase NA Recruiting
20 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡